Vector Therapeutics, Inc.
Pharmaceutical company · New York, United States
Vector Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $240,000 sold in a notice filed in 2017.
Vector Therapeutics at a glance
What does Vector Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $240,000 sold (2017).
Frequently asked questions about Vector Therapeutics
Where is Vector Therapeutics headquartered?
Vector Therapeutics, Inc. is headquartered in New York, United States.
What does Vector Therapeutics do?
Vector Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Vector Therapeutics founded?
The earliest incorporation on record for Vector Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences